News — ASNRT
Latest news, announcements, and updates from the Arab Society of Nephrology and Renal Transplantation. This page publishes society news, congress announcements, AJNT issue releases, partner society updates, and notable developments in Arab nephrology.
Latest Articles
The most recent nephrology and transplantation news curated by ASNRT.
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy · APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape. · Hemodiafiltration versus High-Flux Hemodialysis and Risk of Mortality: A Multinational Target Trial Emulation. · Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial. · Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence. · ABO-Incompatible Kidney Transplantation as a Strategic Expansion Tool in Low- and Middle-Income Countries · Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension. · Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial. · A perspective on ABO incompatible transplantation. · Comparing Catheters with Fistulas in Older Patients Starting Hemodialysis: A Pilot Randomized Controlled Trial. · Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease · Finerenone in Persons with Chronic Kidney Disease without Diabetes. · Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in Diabetic Kidney Disease · Steroid avoidance or withdrawal for kidney transplant recipients. · Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis. · Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and Kdigo 2024. · Randomized Crossover Trial of Low Sodium Dialysate on Tissue Sodium Accumulation in Hemodialysis. · Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis · Clazakizumab in the Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection: Results from the IMAGINE Phase 3 Randomized, Double-Blind, Placebo-Controlled Study · Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3-5: A randomized controlled trial protocol. · A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission. · Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. · Endovascular arteriovenous fistula: Outcomes and comparison with surgical arteriovenous fistula: An updated systematic review and meta-analysis. · Efficacy and safety of belimumab in IgA nephropathy: real-world evidence. · Diabetes Mellitus Attenuates Response to Anti-CD20 Therapy in Primary Membranous Nephropathy Despite Equivalent B-Cell Depletion. · Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus · Finerenone in Type 1 Diabetes and Chronic Kidney Disease. · SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes · Vaccinations to Prevent Infections in Adults with CKD and After Kidney Transplantation: A Review · Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients · Systematic Review of Kidney Transplant Outcomes in Monoclonal Ig Deposition Disease. · FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD Dialysis · Updates on Kidney Transplantation From the World Transplant Congress 2025 · TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198. · Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial · Dual costimulation blockade with the CD154-specific fusion protein dazodalibep and belatacept for prophylaxis of kidney allograft rejection. · Phase 2 Apecotrep Delivers 40% Proteinuria Reduction in FSGS · A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial. · Trends in Nephrology: From nihilism to targeted treatment of antibody-mediated rejection · [What’s new in dialysis in 2025?].
Browse by Topic
News organized by clinical subject.
Transplantation · Dialysis · Glomerulonephritis · CKD · AKI & Critical Care · Hypertension & Diabetic Kidney · Genetic & Cystic · Kidney Stones · Electrolytes & Acid-Base · Pediatric Nephrology · Cardiorenal · Society & Regulatory · General Nephrology · AJNT
Stay Connected
Subscribe to the ASNRT newsletter via the membership portal, or follow our official channels for upcoming congress announcements, journal release notifications, and clinical practice updates.